Clinical trial

To Compare the Pharmacokinetic Characteristics of the Fixed-dose Combination Compared to the Loose Combination

NCT05737771

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2023-01-25

PhasePHASE1

Study timeline

Study start (actual)2023-01-25Date precision: day

Registry last updated2023-02-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

FDCunresolved

Diabetes Mellitus, Type 2unresolved

Interventions

DWC202213DRUG

DWJ1563DRUG

DWP16001DRUG

Sponsors & collaborators

Daewoong Pharmaceutical Co. LTD.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05737771 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.